Q1 FY2027 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Takeda Pharmaceutical Company(TAK) the Revenue is 7.533 B (-1.47%), Beat estimate;the EBIT is 1.244 B (-2.47%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
7.53B1.47%
7.10B7.15%
+0.43B5.68%
EBITExceed expectations
1.24B2.47%
0.96B24.44%
+0.28B21.97%
Upcoming earnings report - FY2027 Q2 Earning Release
Available dateOct 29, 2026
Estimate Revenue7.236 B
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf